Treating Osteoarthritis with Stem Cell Therapy

More than 3 million people in the United States alone suffer from Osteoarthritis, the most common form of arthritis. It occurs when cartilage, the protective tissue between bones, wears down over time until there is next to nothing left. The most common joints to suffer this painful fate include those in the knees, hips, back, hands and neck.

Osteoarthritis primarily affects older Americans but sports injuries can lead to early onset of arthritis for younger patients. Traditional treatment is not a cure in that it only seeks to control pain with medications and enhance mobility with physical therapy. Full joint replacement surgery is often the only way to reverse the damage, but recovery can be painful and lengthy. Additionally, it’s not always safe for aging patients to undergo surgery if it’s not life-threatening.

That’s why here at San Francisco Stem Cell Treatment Center, Dr. Herskowitz has devoted endless time and resources to finding a better, less-invasive treatment for those suffering from joint pain. Scientists have discovered using adult stem cells could help the cartilage regenerate and repair itself. The procedure is simple: stem cells are removed from the patient’s own fat stores and then injected into the site of the joint pain where they go to work immediately to begin the self-healing process.

Adult stem cells provide no ethical concerns and are essentially cells located in your own organs and tissues that have yet to decide what kind of cell they will become. They lie dormant until injury or disease calls them into action. The idea behind this type of therapy is that we relocate the stem cells to where they are needed most for their healing properties. Once relocated, they have the potential to create new cells, in this case cartilage cells, also called chondryte cells.

If you or a loved one suffers from joint pain, regardless of the cause, call us today at 1-800-318-6006 to find out how our stem cell therapy could help improve your quality of life.